464 studies found for:    "Uveal diseases"
Show Display Options
Rank Status Study
1 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
2 Terminated A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
Condition: Anterior Uveitis
Intervention: Drug: Dexamethasone
3 Unknown  Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty
Condition: Corneal Edema Secondary to Corneal Endothelial Dystrophy
Intervention: Procedure: DSEAK
4 Completed Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Condition: Anterior Uveitis
Intervention: Drug: Difluprednate Ophthalmic Emulsion
5 Completed
Has Results
Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
Condition: Uveitis
Intervention: Drug: 0.59 mg Fluocinolone Acetonide implant
6 Terminated
Has Results
Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration
Conditions: Subfoveal Choroidal Neovascularization;   Age-Related Maculopathy
Interventions: Drug: 700 ug dexamethasone;   Biological: ranibizumab;   Other: sham
7 Completed
Has Results
Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)
Conditions: Choroidal Neovascularization;   Age-Related Maculopathy
Interventions: Drug: dexamethasone;   Biological: ranibizumab
8 Recruiting Study of Endothelial Keratoplasty Outcomes
Conditions: Fuchs' Endothelial Corneal Dystrophy;   Bullous Keratopathy;   Iridocorneal Endothelial Syndrome;   Posterior Polymorphous Dystrophy
Intervention: Procedure: endothelial keratoplasty
9 Terminated
Has Results
Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
Conditions: Intraocular Melanoma;   Malignant Conjunctival Neoplasm
Interventions: Drug: cyclophosphamide;   Drug: lenalidomide;   Drug: sunitinib malate
10 Completed
Has Results
Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)
Condition: Age-related Macular Degeneration
Intervention: Drug: Ranibizumab 0.5 mg
11 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples
12 Completed Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Extraocular Extension Melanoma;   Recurrent Intraocular Melanoma
Interventions: Drug: gp100 antigen;   Drug: interleukin-2;   Drug: MART-1 antigen;   Drug: Montanide ISA-51
13 Completed Eye and Immunogenetic Features of Sarcoidosis
Conditions: Sarcoidosis;   Uveitis
14 Recruiting CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Extraocular Extension Melanoma;   Iris Melanoma;   Metastatic Carcinoma of Unknown Primary;   Metastatic Intraocular Melanoma;   Mucosal Melanoma;   Stage IIB Intraocular Melanoma;   Stage IIB Melanoma;   Stage IIC Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIA Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIB Melanoma;   Stage IIIC Intraocular Melanoma;   Stage IIIC Melanoma;   Stage IV Intraocular Melanoma;   Stage IV Melanoma
Interventions: Biological: recombinant flt3 ligand;   Biological: DEC-205/NY-ESO-1 fusion protein CDX-1401;   Biological: neoantigen-based melanoma-poly-ICLC vaccine;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Completed
Has Results
Ranibizumab and Reduced Fluence PDT for AMD
Condition: Macular Degeneration
Interventions: Drug: ranibizumab;   Drug: verteporfin
16 Completed Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin);   Metastatic Cancer
Interventions: Drug: melphalan;   Drug: regional chemotherapy;   Drug: systemic chemotherapy;   Procedure: hepatic artery embolization
17 Completed Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
Condition: Choroidal Neovascularization
18 Recruiting Imaging Lens Deposits in Exfoliation Syndrome
Conditions: Exfoliation Syndrome;   Primary Open Angle Glaucoma;   Cataracts
Intervention: Device: anterior segment OCT
19 Completed
Has Results
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
Conditions: Uveitis;   Cystoid Macular Edema
Intervention: Drug: Pegaptanib
20 Unknown  TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration
Condition: Choroidal Neovascularization
Intervention: Procedure: Photodynamic therapy versus Transpupillary thermotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years